This text investigates how genomic and bioinformatic methodologies can be systematically applied to identify novel antibacterial targets and accelerate the development of therapeutic agents in the postgenomic era. Thomas J. Dougherty, an expert in the field, synthesizes current research to provide a framework for navigating the complexities of bacterial resistance. The book utilizes data-driven approaches to bridge the gap between genomic sequencing and the practical validation of vaccine candidates and broad-spectrum antibiotics.

Experts recognize this work as a technical reference for researchers and students involved in pharmaceutical development and microbiology. Readers frequently note the academic density of the prose, which serves as a foundational guide for those applying genomic data to clinical drug discovery challenges.